Carboxylic Acids And Salts Thereof Patents (Class 562/400)
  • Patent number: 7790134
    Abstract: A method of purifying isosaccharinate by mixing sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide with calcium isosaccharinate, removing the precipitated calcium carbonate and adjusting the pH to between approximately 4.5 to 5.0 thereby removing excess carbonate and hydroxide to provide an acidic solution containing isosaccharinate.
    Type: Grant
    Filed: April 2, 2008
    Date of Patent: September 7, 2010
    Assignee: Sandia Corporation
    Inventors: Dhanpat Rai, Robert C. Moore, Mark D. Tucker
  • Publication number: 20100222609
    Abstract: In a process for oxidizing a hydrocarbon to a corresponding hydroperoxide, alcohol, ketone, carboxylic acid or dicarboxylic acid, the hydrocarbon is contacted with an oxygen-containing gas in the presence of a catalyst comprising a cyclic imide of the general formula (I): wherein each of R1 and R2 is independently selected from hydrocarbyl and substituted hydrocarbyl radicals having 1 to 20 carbon atoms, or from the groups SO3H, NH2, OH and NO2, or from the atoms H, F, Cl, Br and I provided that R1 and R2 can be linked to one another via a covalent bond; each of Q1 and Q2 is independently selected from C, CH, N and CR3; each of X and Z is independently selected from C, S, CH2, N, P and elements of Group 4 of the Periodic Table; Y is O or OH; k is 0, 1, or 2; 1 is 0, 1, or 2; m is 1 to 3, and R3 can be any of the entities listed for R1.
    Type: Application
    Filed: October 8, 2008
    Publication date: September 2, 2010
    Inventors: Jihad M. Dakka, James C. Vartuli, Stephen Zushma
  • Patent number: 7786161
    Abstract: A carboxylic acid derivative of formula (I): wherein R1 is —COOH, —COOR6, etc.; A is a single bond, alkylene, etc.; R2 is alkyl, alkoxy, etc.; B is a carbocyclic ring or a heterocyclic ring; Q is alkylnene-Cyc2, etc.; D is a linking chain; and R3 is alkyl, a carbocyclic ring or a heterocyclic ring, or a non-toxic salt thereof. The compound of formula (I) binds to PGE2 receptor, especially subtypes EP3 and/or EP4 and show the antagonizing activity, are useful for the prevention and/or treatment of diseases induced pain, itch, urticaria, allergy, urinary frequency, urinary disturbance, Alzheimer's disease, cancer, dysmenorrhea, endometriosis, etc.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: August 31, 2010
    Assignee: ONO Pharmaceutical Co., Ltd.
    Inventors: Kousuke Tani, Masaki Asada, Kaoru Kobayashi, Masami Narita, Mikio Ogawa
  • Patent number: 7786314
    Abstract: Processes for the preparation of certain [3.1.0]hexane derivatives which are useful as mGluR agonists, and intermediates prepared during such processes.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: August 31, 2010
    Assignee: Taisho Pharmaceutical Co., Ltd
    Inventors: Frederick W. Hartner, Lushi Tan, Nobuyoshi Yasuda, Naoki Yoshikawa
  • Patent number: 7786321
    Abstract: The invention concerns novel compounds of the N-acylamino-amide family, compositions, in particular cosmetic or pharmaceutical, containing them, and their use for treating body or face skin ageing, whether chronobiologic or light-induced, and in particular skin ageing caused by decrease of skin elasticity and/or by collagen degradation in the structure for tissues.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: August 31, 2010
    Assignee: L'Oreal S.A.
    Inventors: Maria Dalko, Yann Mahe, Lionel Breton
  • Publication number: 20100210871
    Abstract: The invention relates to a process for converting ammonium salts of organic acids to the particular free organic acid, wherein an aqueous solution of the ammonium salt is contacted with an organic extractant and the salt is dissociated at temperatures and pressures at which the aqueous solution and the extractant are in the liquid state, and a stripping medium or entraining gas is introduced in order to remove NH3 from the aqueous solution and transfer at least a portion of the free organic acid formed to the organic extractant. The invention described here thus provides an improved process for releasing an organic acid, preferably a carboxylic, sulphonic or phosphonic acid, especially an alpha-hydroxycarboxylic acid or beta-hydroxycarboxylic acid, from the ammonium salt thereof by release and removal of ammonia and simultaneous extraction of the acid released with a suitable extractant from the aqueous phase. This process corresponds to a reactive extraction.
    Type: Application
    Filed: February 16, 2010
    Publication date: August 19, 2010
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Christoph Kobler, Dieter Buss, Axel Ronneburg, Christoph Weckbecker
  • Patent number: 7777072
    Abstract: 2,5-dihydroxyterephthalic acid is produced in high yields and high purity from 2,5-dihaloterephthalic acid by contact with a copper source and a ligand that coordinates to copper under basic conditions.
    Type: Grant
    Filed: March 4, 2008
    Date of Patent: August 17, 2010
    Assignee: E.I. du Pont de Nemours and Company
    Inventor: Joachim C. Ritter
  • Patent number: 7767867
    Abstract: Disclosed are methods for generating propylene glycol, ethylene glycol and other polyols, diols, ketones, aldehydes, carboxylic acids and alcohols from biomass using hydrogen produced from the biomass. The methods involve reacting a portion of an aqueous stream of a biomass feedstock solution over a catalyst under aqueous phase reforming conditions to produce hydrogen, and then reacting the hydrogen and the aqueous feedstock solution over a catalyst to produce propylene glycol, ethylene glycal and the other polyols, diols, ketones, aldehydes, carboxylic acids and alcohols. The disclosed methods can be run at lower temperatures and pressures, and allows for the production of oxygenated hydrocarbons without the need for hydrogen from an external source.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: August 3, 2010
    Assignee: Virent Energy Systems, Inc.
    Inventor: Randy D. Cortright
  • Patent number: 7759517
    Abstract: The present invention relates to a process for the preparation of gabapentin and, more in particular, to a method of synthesis of 1,1-cyclohexane acetic acid monoamide, an intermediate used in the preparation of gabapentin, comprising the basic hydrolysis reaction of ?, -diaminocarbonyl-?,?-pentamethylene glutarimide.
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: July 20, 2010
    Assignee: Zach System S.P.A.
    Inventors: Marco Villa, Maurizio Paiocchi, Katiuscia Arrighi, Francesco Corcella, Vincenzo Cannata, Giorgio Soriato, Massimo Verzini
  • Patent number: 7754675
    Abstract: Optionally isolated and/or purified enatiomers of 2-heptylcyclopropyl-1-carboxylic acid and mixtures of two, three or all enantiomers of 2-heptylcyclopropyl-1-carboxylic acid are disclosed as perfumes and/or flavourings.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: July 13, 2010
    Assignee: Symrise GmbH & Co. KG
    Inventors: Sabine Widder, Jan Looft, Armin Van Der Kolk, Tobias Vössing, Wilhelm Pickenhagen, Birgit Kohlenberg
  • Publication number: 20100152485
    Abstract: In accordance with the teachings of the present invention, a system and method converting biomass into useful chemicals are provided. In a particular embodiment, the method includes fermenting biomass in one or more fermentors to produce a fermentation broth comprising ammonium carboxylate salts, the fermentors containing an ammonium carbonate or ammonium bicarbonate buffer. The method further includes reacting the ammonium carboxylate salts from the fermentors with a high-molecular-weight amine to produce amine carboxylate salt, and thermally cracking the amine carboxylate salt to produce carboxylic acid. In another embodiment, the ammonium carboxylate salts from the fermentors may be reacted with a low-molecular-weight amine to produce a low-molecular-weight-amine carboxylate salt.
    Type: Application
    Filed: February 3, 2010
    Publication date: June 17, 2010
    Applicant: TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Mark T. Holtzapple, Richard R. Davison, Cesar B. Granda, Frank K. Agbogbo, Zhihong Fu
  • Publication number: 20100152435
    Abstract: Processes for oxidation of primary alcohols or aldehydes into the corresponding carboxylic acids are provided herein, including processes for the aerobic catalytic oxidation of a hydroxyl moiety pendant to a cyclic carbohydrate to a carboxylic acid in a manner that preserves the cyclic carbohydrate structure. The oxidation processes may be performed in the absence of a transition metal catalyst, halogenated solvent and a hypochlorite reagent. The processes and compositions with and without a bromide source are provided. A liquid reaction media comprising a carboxylic acid and a catalyst composition may be combined with the reactant alcohol substrate to form a reaction media which can be pressurized at constant volume with an oxygen-containing gas under conditions of temperature and constant pressure within a reaction vessel to selectively oxidize the reactant substrate to form a carboxylic acid product.
    Type: Application
    Filed: March 14, 2008
    Publication date: June 17, 2010
    Inventors: Jonathan A. Stapley, Setrak K. Tanielyan, Robert L. Augustine, Norman M. Marin Astorga, Gabriela D. Alvez Manoli
  • Patent number: 7737178
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: June 15, 2010
    Assignee: The Brigham and Woman's Hospital, Inc.
    Inventors: Charles N. Serhan, Clary B. Clish
  • Publication number: 20100144045
    Abstract: The invention relates to the use of compounds as new chiral selectors for separating the optical or enantiomeric isomers of a compound, wherein the chiral selector comprises at least one compound of formula (I): and at least one metal ion, for example Cu2+, Ni2+, Zn2+, Cd2+ or Co2+.
    Type: Application
    Filed: March 13, 2008
    Publication date: June 10, 2010
    Inventors: Eric Peyrin, Jean-Luc Decout, Corrine Ravelet, Isabelle Henriette Baussanne
  • Patent number: 7714017
    Abstract: Peri-substituted, fused bicyclic ring carboxylic acids useful for the treatment or prophylaxis of a prostaglandin-mediated disease or condition are disclosed.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: May 11, 2010
    Assignee: Decode Genetics, EHF
    Inventors: Jasbir Singh, Mark Gurney, Georgeta Hategan, Peng Yu, David Zembower, Nian Zhou, Alexandre Mikhaylovich Polozov, Wayne Edward Zeller
  • Patent number: 7714008
    Abstract: The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
    Type: Grant
    Filed: September 6, 2007
    Date of Patent: May 11, 2010
    Assignee: Amgen Inc.
    Inventors: Hilary Beck, Paul Dransfield, Zice Fu, Jonathan B. Houze, XianYun Jiao, Todd J. Kohn, SuJen Lai, Jinqian Liu, Jiwen Liu, Zhihua Ma, Julio C. Medina, Michael J. Schmitt, Rajiv Sharma, Wang Shen, Marc Vimolratana, Yingcai Wang, Zhongyu Wang
  • Patent number: 7709659
    Abstract: Tetraphosphorous ligands are combined with transition metal salts to form catalysts for use in hydroformylation, isomerization-hydroformylation, hydrocarboxylation, hydrocyan-ation, isomerization-formylation, hydroaminomethylation and similar related reactions.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: May 4, 2010
    Assignee: The Penn State Research Foundation
    Inventors: Xumu Zhang, Yongjun Yan
  • Publication number: 20100105864
    Abstract: A compound which is able to activate a calcium receptor can be used as an active ingredient of a prophylactic or therapeutic agent for treating diarrhea. The compound can be a peptide such as ?-Glu-X-Gly (X represents an amino acid or an amino acid derivative), ?-Glu-Val-Y (Y represents an amino acid or an amino acid derivative), ?-Glu-Ala, ?-Glu-Gly, ?-Glu-Cys, ?-Glu-Met, ?-Glu-Thr, ?-Glu-Val, ?-Glu-Orn, Asp-Gly, Cys-Gly, Cys-Met, Glu-Cys, Gly-Cys, Leu-Asp, ?-Glu-Met(O), ?-Glu-?-Glu-Val, ?-Glu-Val-NH2, ?-Glu-Val-ol, ?-Glu-Ser, ?-Glu-Tau, ?-Glu-Cys(S-Me)(O), ?-Glu-Leu, ?-Glu-Ile, ?-Glu-t-Leu, and ?-Glu-Cys(S-Me).
    Type: Application
    Filed: November 6, 2009
    Publication date: April 29, 2010
    Inventors: Junya Yoneda, Tetsuo Yano, Yukie Seki, Yuzuru Eto, Yusuke Amino
  • Publication number: 20100094045
    Abstract: Disclosed is a method for producing at least one of an ?,?-unsaturated aldehyde and an ?,?-unsaturated carboxylic acid from an alcohol in a liquid phase through a simple process. Namely, at least one of an ?,?-unsaturated aldehyde and an ?,?-unsaturated carboxylic acid is produced by dehydrating and oxidizing an alcohol in a liquid phase at 110 to 250° C. in the presence of molecular oxygen and a noble metal-containing catalyst. Alternatively, at least one of an ?,?-unsaturated aldehyde and an ?,?-unsaturated carboxylic acid is produced by dehydrating and oxidizing an alcohol in a liquid phase in the presence of molecular oxygen, a noble metal-containing catalyst, and an acidic substance.
    Type: Application
    Filed: October 3, 2006
    Publication date: April 15, 2010
    Applicant: MITSUBISHI RAYON CO., LTD
    Inventors: Akio Takeda, Yuji Fujimori, Seiichi Kawato
  • Patent number: 7695891
    Abstract: A photosensitive composition comprising a compound capable of generating a compound having a specific structure upon irradiation with actinic rays or radiation; a pattern forming method using the photosensitive composition; a compound having a specific structure; and a compound capable of generating a compound having a specific structure upon irradiation with actinic rays or radiation.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: April 13, 2010
    Assignee: FUJIFILM Corporation
    Inventor: Kenji Wada
  • Publication number: 20100088782
    Abstract: Described herein are inventions in the field of genetic engineering of plants, including combinations of nucleic acid molecules encoding pyruvate kinase subunits to improve agronomic, horticultural, and quality traits. This invention relates generally to the combination of nucleic acid sequences encoding pyruvate kinase proteins that are related to the presence of seed storage compounds in plants. More specifically, the present invention relates to the use of these combinations of these sequences, their order and direction in the combination, and the regulatory elements used to control expression and transcript termination in these combinations in transgenic plants. In particular, the invention is directed to methods for manipulating seed storage compounds in plants and seeds. The invention further relates to methods of using these novel combinations of polypeptides to stimulate plant growth and/or root growth and/or to increase yield and/or composition of seed storage compounds.
    Type: Application
    Filed: April 29, 2008
    Publication date: April 8, 2010
    Inventors: Oliver Oswald, Heiko A. Härtel, Christoph Benning, Carl Andre
  • Publication number: 20100076080
    Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.
    Type: Application
    Filed: August 14, 2009
    Publication date: March 25, 2010
    Inventors: Kenneth Edward Yelm, Gregory Mark Bunke, John Christian Haught
  • Publication number: 20100069618
    Abstract: The invention concerns a process for preparing a hybrid organic-inorganic material (HOIM) with phosphorus-containing bridges between the surface of an inorganic substrate containing an element M and one or more organic groups of the covalent M-O-P-R type, said process using, as a precursor for said organic group or groups, at least one organophosphorus acid halide with formula RxP(O)Xy in which x=1 or 2, y=3?x, X being a halogen and R designating at least one organic alkyl, aryl or aryl-alkyl group. Non-exhaustive applications for the hybrid organic-inorganic material obtained by the process of the invention are in the fields of anti-corrosion, lubrication, microelectronics, nanotechnologies, composite materials, heterogeneous catalysis, supported catalysis, depollution and biomedical applications.
    Type: Application
    Filed: July 6, 2007
    Publication date: March 18, 2010
    Applicant: IFP
    Inventors: Renaud Revel, Florence Brodard-Severac, Gilles Guerrero, Hubert Mutin, Alain Forestiere, Alexandra Chaumonnot
  • Publication number: 20100069606
    Abstract: Devices, compositions, and methods are described which provide a tubular nanostructure targeted to a lipid bilayer membrane. The targeted tubular nanostructure can have a surface region configured to pass through a lipid bilayer membrane of a cell, a hydrophobic surface region flanked by two hydrophilic surface regions configured to form a pore in a lipid bilayer membrane of a cellular organelle, and at least one ligand configured to bind one or more cognates on the lipid bilayer membrane of the cellular organelle. The target cell can be, for example, a tumor cell, an infected cell, or a diseased cell in a subject. The tubular nanostructure can form a pore in the lipid bilayer membrane of the cellular organelle, e.g., mitochondria, which can permit transit or translocation of at least one compound across the membrane and cause cell death of the target cell.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 18, 2010
    Inventors: Mahalaxmi Gita Bangera, Ed Harlow, Roderick A. Hyde, Muriel Y. Ishikawa, Edward K.Y. Jung, Eric C. Leuthardt, Nathan P. Myhrvold, Dennis J. Rivet, Elizabeth A. Sweeney, Clarence T. Tegreene, Lowell L. Wood, JR., Victoria Y.H. Wood
  • Patent number: 7678365
    Abstract: This invention relates generally to compositions and methods useful for oral hygiene rinses, and more specifically to oral rinses in which the antimicrobial activity of chlorous acid is supplemented by that of lactic acid as one of a combination of antimicrobial acids, preferably acids which serve to partially convert chlorite ion to chlorous acid.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: March 16, 2010
    Inventor: Robert D. Kross
  • Publication number: 20100051509
    Abstract: Ionic liquids of the general formula C+A? where C+ represents an organic cation, specifically, but not limited to the imidazolium, pyridinium, isoquinolinium, ammonium types, which have aliphatic and aromatic substituents, while A? represents a carboxylate, aromatic and aliphatic anion. The ionic liquids are synthesized under conventional heating or microwave irradiation This invention is also related to the application of ionic liquids to remove sulfur compounds of naphthas through a liquid-liquid extraction and the recovery and reuse of ionic liquids by the application of heat, reduced pressure and washing with solvents.
    Type: Application
    Filed: August 27, 2009
    Publication date: March 4, 2010
    Applicant: INSTITUTO MEXICANO DEL PETROLEO
    Inventors: Rafael Martinez Palou, Natalya Victorovna Likhanova, Eugenio Alejandro Flores Oropeza, Diego Javier Guzman Lucero
  • Patent number: 7670986
    Abstract: A manganese dioxide catalyst for hydrolysing organic nitrites which bear readily oxidizable groups such as thiol or thioether groups to the corresponding carboxamides, and to a process for preparing the catalyst and to its use for hydrolysing organic nitrites.
    Type: Grant
    Filed: October 5, 2006
    Date of Patent: March 2, 2010
    Assignee: Degussa AG
    Inventors: Horst Weigel, Axel Ronneburg, Christoph Weckbecker
  • Patent number: 7671043
    Abstract: The invention relates to compounds of formula I and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof; wherein B, D, E, R1, R2, R3, R4, R5, R8, m, n, p, q, r, s, t and u are as defined herein. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: March 2, 2010
    Assignee: Pfizer Inc
    Inventor: Robert John Maguire
  • Patent number: 7662863
    Abstract: A therapeutic method and associated compound for ameliorating alcohol intoxication and preventing and/or reducing hangover symptoms. Glucaric acid, any salt thereof, and/or any derivative or metabolized form thereof is provided in therapeutic dosage, before and/or after the intake of alcohol.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: February 16, 2010
    Inventors: Alan Andrews, Christine Fields, Allison Minton, Brian Slaga, Sean Traci, Loretta Zapp
  • Publication number: 20090320148
    Abstract: Disclosed are novel oxylipins that are derived from ?-linolenic acid (GLA; 18:3n-6) and stearidonic acid (STA or SDA; 18:4n-3), and methods of making and using such oxylipins. Also disclosed is the use of such oxylipins in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. Also disclosed are The invention novel ways of producing long chain polyunsaturated acid (LCPUF A)-rich oils and compositions that contain enhanced and effective amounts of SDA- and/or GLA-derived oxylipins.
    Type: Application
    Filed: January 31, 2007
    Publication date: December 24, 2009
    Applicant: MARTEK BIOSCIENCES CORPORATION
    Inventors: Linda Mary Aaterburn, William Barclay, Bindi Dangi, James Flatt, Jung Lee, Dutt Vinjamoori
  • Publication number: 20090318712
    Abstract: Catalyst systems for preparing carboxylic acids and/or anhydrides, the catalyst system comprising a reaction zone and a layered catalyst, the reaction zone comprises a gas inlet region and a gas outlet region, the layered catalyst comprises an active composition and one or more middle layers, one or more first layers disposed on a side of the one or more middle layers toward the gas inlet region, and one or more second layers on a side of the one or more middle layers toward the gas outlet region, wherein the active composition content of one or more of the middle catalyst layers, based on total mass of the layered catalyst, is lower than the active composition content of the one or more first catalyst layers and is lower than one or more second catalyst layers; and processes for gas phase oxidation employing a layered catalyst of the present invention.
    Type: Application
    Filed: June 6, 2007
    Publication date: December 24, 2009
    Applicant: BASF SE
    Inventors: Hagen Wilmer, Cornelia Dobner, Tina Einfeld, Sebastian Storck, Jürgen Zühlke, Frank Rosowski
  • Publication number: 20090312315
    Abstract: The compound represented by the following formula (I) and the like have PAI-1 inhibition activity; wherein: R1 represents a C6-10 aryl group which may be substituted or the like; T represents a single bond or the like; m represents 0 or 1; when m is 0, G represents —N—C(?O)—CO2H or the like; when m is 1, G represents an oxygen atom or the like; R2 represents a C6-10 aryl group which may be substituted or the like; E represents the following formula (II) wherein one of R31, R32, R33 and R34 represents the formula R1-T-, each of the other three independently represents a hydrogen atom or the like, and R35 represents the formula —X—Y?, a hydrogen atom or the like; X represents —CH2— or the like; Y? represents a carboxy group or the like; M represents a single bond or the like.
    Type: Application
    Filed: April 10, 2009
    Publication date: December 17, 2009
    Inventors: Youichi Yamaguchi, Takeshi Yanase, Susumu Muto, Akiko Itai
  • Publication number: 20090312569
    Abstract: The present invention relates to a process for the preparation of 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid which is useful as an intermediate in the preparation of pharmaceutically active compounds.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 17, 2009
    Inventor: Bruno Lohri
  • Publication number: 20090311300
    Abstract: The invention relates to a stent with in particular a coated basic body made of an implant material the use of lithium salts as a coating material or a component of an implant material for stents and the use of lithium salts in a method for restenosis prevention. The inventive stent having a basic body made of an implant material is characterized in that (i) the basic body has a coating which comprises or consists of a lithium salt, and/or (ii) the implant material is biocorrodible and the basic body contains a lithium salt.
    Type: Application
    Filed: June 2, 2009
    Publication date: December 17, 2009
    Inventor: Eric Wittchow
  • Publication number: 20090306340
    Abstract: The present invention provides: a method for purifying an oligopeptide, which comprises a step of contacting a solution comprising the oligopeptide and a neutral amino acid with an ion exchange resin in an effective pH range; the method for purifying an oligopeptide, which comprises (a) a step of passing a solution comprising the oligopeptide and the neutral amino acid through a column packed with an ion exchange resin, and (b) a step of eluting the oligopeptide contacted with the ion exchange resin with an eluting solvent; the above method using a weakly acidic cation exchange resin; the above method using a weakly basic anion exchange resin, etc.
    Type: Application
    Filed: June 28, 2007
    Publication date: December 10, 2009
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Shizuo Tsuchiya, Tetsuo Nishimura, Toshikatsu Shindo
  • Publication number: 20090306228
    Abstract: The present invention relates to active agent delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to active agents and methods for administering conjugated active agent compositions.
    Type: Application
    Filed: November 1, 2007
    Publication date: December 10, 2009
    Applicant: SHIRE LLC
    Inventors: Travis Mickle, Suma Krishnan, James Scott Moncrief, Christopher Lauderback, Thomas Piccariello, Randal Kirk
  • Publication number: 20090306425
    Abstract: A process for the production of carboxylic acids by oxidation of a hydrocarbon by oxygen or a gas containing oxygen and notably to the oxidation of cyclohexane to give adipic acid; the subject process entails a stage of oxidation of the hydrocarbon and at least one stage for extracting the dicarboxylic acids formed from the reaction medium and optionally recycling the unconverted hydrocarbon with oxidation by-products, such as alcohols and ketones, and which also includes a stage of conversion, removal or extraction of the ?,?-hydroxycarboxylic compounds formed during the oxidation stage and converting these compounds into diacids.
    Type: Application
    Filed: June 9, 2006
    Publication date: December 10, 2009
    Inventors: Didier Bonnet, Romain Petroff Saint-Arroma, Sebastien Righini, Tania Ireland, Jean-Pierre Simonato
  • Patent number: 7629488
    Abstract: The present invention is directed to novel processes for the preparation of opioid modulators (agonists and antagonists) and intermediates in their synthesis. The opioid modulators are useful for the treatment and prevention of as pain and gastrointestinal disorders.
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: December 8, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Chaozhong Cai, Wei He
  • Patent number: 7626053
    Abstract: Hydroxy aromatic acids are produced in high yields and high purity (>95%) from halogenated aromatic acids in a reaction mixture containing a copper source and a ligand that coordinates to copper.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: December 1, 2009
    Assignee: E.I. du Pont de Nemours and Company
    Inventor: Joachim C. Ritter
  • Patent number: 7622499
    Abstract: The present invention relates to photosensitive derivatives of optically active L-threo-?-benzyloxyaspartate or its benzene ring-substituted analogs, represented by the following formula (1) or (2): (1) (2) wherein R1 represents hydrogen atom, amino group, straight or branched lower aliphatic acylamino group optionally substituted at the acyl group portion, alicyclic acylamino group or aromatic acylamino group optionally having a substituent on the aromatic ring, R2 represents hydrogen atom or one or more straight or branched optionally substituted lower aliphatic alkyloxy groups on the benzene ring, R3 represents hydrogen atom, methyl group or carboxyl group, and R4 and R5 each represent hydrogen atom, hydroxyl group, straight or branched lower alkyloxy group optionally substituted at the alkyl portion, amino group, straight or branched lower alkyl-substituted amino group, or a halogen atom, which upon photoirradiation can produce compounds exhibiting a function of suppressing the glutamate uptake activity o
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: November 24, 2009
    Assignee: Suntory Holdings Limited
    Inventors: Keiko Shimamoto, Kiyo Takaoka
  • Patent number: 7612068
    Abstract: The present invention relates to compounds of formula I wherein the substituents are as defined below. The compounds of formula I are useful for the treatment of diseases such as schizophrenia, including both the positive and the negative symptoms of schizophrenia and other psychoses.
    Type: Grant
    Filed: April 27, 2004
    Date of Patent: November 3, 2009
    Assignee: H. Lundbeck A/S
    Inventors: Garrick P. Smith, Gitte K. Mikkelsen, Kim Andersen, Daniel R. Greve, Jorgen Eskildsen
  • Publication number: 20090253928
    Abstract: A process for the preparation of a compound of formula (Ia): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 8, 2009
    Inventors: Gerard John Harnett, Ursula Hoffmann, Michael Jansen, Reinhard Reents, Tim Sattelkau, Dennis A. Smith, Helmut Stahr
  • Publication number: 20090253927
    Abstract: A process for the preparation of a compound of formula (I): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 8, 2009
    Inventors: Ursula Hoffmann, Michael Jansen, Reinhard Reents, Helmut Stahr
  • Publication number: 20090221847
    Abstract: Disclosed is a method of a gas-phase catalytic oxidation reaction of propylene, isobutylene, or tertiary butanol with molecular oxygen in the presence of a catalyst to produce a corresponding unsaturated aldehyde and a corresponding unsaturated carboxylic acid, in which the catalyst can be used over a long period of time. Concretely, in the presence of the catalyst containing a complex oxide including molybdenum, bismuth and iron as essential components, at least one factor of a reaction pressure and a molar ratio of molecular oxygen to a raw material is controlled to change in such a way that a rate of reaction of the raw material is kept constant in the temperature range of from (TA-15)° C. to TA° C., when a boundary temperature of the activation energy of the catalyst is set to be TA° C.
    Type: Application
    Filed: March 6, 2007
    Publication date: September 3, 2009
    Applicant: Mitsubishi Rayon Co., Ltd.
    Inventors: Masahide Kondo, Seiichi Kawato, Toru Kuroda
  • Publication number: 20090216044
    Abstract: An object of the present invention is to provide a method for synthesis of keto acids by hydration of an acetylene compound (acetylene-carboxylic acids) under mild conditions free from harmful mercury catalysts and a method for synthesis of amino acids from acetylene-carboxylic acids in a single container (one-pot or tandem synthesis). In one embodiment of the method according to the present invention for synthesis of keto acids, acetylene-carboxylic acids is hydrated in the presence of a metal salt represented by General Formula (1), where M1 represents an element in Group VIII, IX, or X of the periodic table, and X1, X2, or X3 ligand represents halogen, H2O, or a solvent molecule, and k represents a valence of a cation species, and Y represents an anion species, and L represents a valence of the anion species, and each of K and L independently represents 1 or 2, and k×m=L×n.
    Type: Application
    Filed: September 13, 2006
    Publication date: August 27, 2009
    Applicant: Japan Science and Technology Agency
    Inventors: Seiji Ogo, Shun-ichi Fukuzumi
  • Patent number: 7576237
    Abstract: 2,5-dihydroxyterephthalic acid is produced in high yields and high purity from 2,5-dihaloterephthalic acid by contact with a copper source and a ligand that coordinates to copper under basic conditions.
    Type: Grant
    Filed: March 26, 2008
    Date of Patent: August 18, 2009
    Assignee: E.I. du Pont de Nemours and Company
    Inventor: Joaquim C. Ritter
  • Publication number: 20090198071
    Abstract: Tetraphosphorous ligands are combined with transition metal salts to form catalysts for use in hydroformylation, isomerization-hydroformylation, hydrocarboxylation, hydrocyan-ation, isomerization-formylation, hydroaminomethylation and similar related reactions.
    Type: Application
    Filed: April 17, 2009
    Publication date: August 6, 2009
    Applicant: THE PENN STATE RESEARCH FOUNDATION
    Inventors: Xumu ZHANG, Yongjun Yan
  • Publication number: 20090188869
    Abstract: Multi-layered macromolecules wherein the layers are covalently bonded together and wherein the macromolecules are covalently bonded to solid particulate substrates, methods for the preparation of such compositions, and methods for their uses in a multitude of end use applications ranging from the purification of waste chemical and metal process streams to the separation and identification of proteins, peptides, and oligionucleotides.
    Type: Application
    Filed: May 2, 2008
    Publication date: July 30, 2009
    Inventors: Charles E. Skinner, William Henry Campbell, Yung K. Kim
  • Publication number: 20090171109
    Abstract: The present invention relates to an integrated process for producing unsaturated carboxylic acids from the corresponding C2-C4 alkane. The process begins with performance of thermally integrated dehydrogenation reactions which convert a C2-C4 alkane to its corresponding C2-C4 alkene, and which involve exothermically converting a portion of an alkane to its corresponding alkene by oxidative dehydrogenation in an exothermic reaction zone, in the presence of oxygen and a suitable catalyst, and then feeding the products of the exothermic reaction zone to an endothermic reaction zone wherein at least a portion of the remaining unconverted alkane is endothermically dehydrogenated to form an additional quantity of the same corresponding alkene, in the presence of carbon dioxide and an other suitable catalyst.
    Type: Application
    Filed: December 11, 2008
    Publication date: July 2, 2009
    Inventors: Abraham Benderly, Nitin Chadda, Douglass Sevon
  • Patent number: 7553794
    Abstract: A supported catalyst comprising a support having supported thereon at least one member selected from the group consisting of heteropolyacids and heteropolyacid salts, in which the heteropolyacid and/or heteropolyacid salt is substantially present in a surface layer region of the support to a depth of 30% from the support surface. The catalyst has a high performance when used for the production of compounds by various reactions.
    Type: Grant
    Filed: November 27, 2003
    Date of Patent: June 30, 2009
    Assignee: Showa Denko K.K.
    Inventor: Masaaki Sakai